0001209191-16-111161.txt : 20160330
0001209191-16-111161.hdr.sgml : 20160330
20160330210048
ACCESSION NUMBER: 0001209191-16-111161
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160328
FILED AS OF DATE: 20160330
DATE AS OF CHANGE: 20160330
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-731-8389
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blackburn Kelly
CENTRAL INDEX KEY: 0001640575
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 161541470
MAIL ADDRESS:
STREET 1: C/O ATYR PHARMA, INC.
STREET 2: 3545 JOHN HOPKINS COURT, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-03-28
0
0001339970
aTYR PHARMA INC
LIFE
0001640575
Blackburn Kelly
3545 JOHN HOPKINS COURT, SUITE 250
SAN DIEGO, CA
CA
92121
0
1
0
0
VP, Clinical Affairs
Restricted Stock Unit
2016-03-28
4
A
0
21600
0.00
A
Common Stock
21600
21600
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
1/2 of the restricted stock units are scheduled to vest on March 28, 2017 and the remaining 1/2 are scheduled to vest on March 28, 2018. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
/s/ Nancy Krueger, as Power of Attorney
2016-03-30